BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 19016071)

  • 1. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.
    Al-Qallaf B; Das DB
    J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
    Al-Qallaf B; Das DB
    Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling transdermal delivery of high molecular weight drugs from microneedle systems.
    Al-Qallaf B; Das DB; Mori D; Cui Z
    Philos Trans A Math Phys Eng Sci; 2007 Dec; 365(1861):2951-67. PubMed ID: 17890186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple method of microneedle array fabrication for transdermal drug delivery.
    Kochhar JS; Goh WJ; Chan SY; Kang L
    Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
    Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
    Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microneedles: an emerging transdermal drug delivery system.
    Bariya SH; Gohel MC; Mehta TA; Sharma OP
    J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in polymer microneedle for transdermal drug delivery.
    Ahmed Saeed Al-Japairai K; Mahmood S; Hamed Almurisi S; Reddy Venugopal J; Rebhi Hilles A; Azmana M; Raman S
    Int J Pharm; 2020 Sep; 587():119673. PubMed ID: 32739388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin.
    Verbaan FJ; Bal SM; van den Berg DJ; Groenink WH; Verpoorten H; Lüttge R; Bouwstra JA
    J Control Release; 2007 Feb; 117(2):238-45. PubMed ID: 17196697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
    Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
    J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microneedles for transdermal drug delivery: a minireview.
    Vandervoort J; Ludwig A
    Front Biosci; 2008 Jan; 13():1711-5. PubMed ID: 17981662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population.
    Duarah S; Sharma M; Wen J
    Eur J Pharm Biopharm; 2019 Mar; 136():48-69. PubMed ID: 30633972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview on the advantages and limitations of 3D printing of microneedles.
    Ozyilmaz ED; Turan A; Comoglu T
    Pharm Dev Technol; 2021 Nov; 26(9):923-933. PubMed ID: 34369288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current advances in the fabrication of microneedles for transdermal delivery.
    Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
    J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations in the use of microneedles: pain, convenience, anxiety and safety.
    Jeong HR; Lee HS; Choi IJ; Park JH
    J Drug Target; 2017 Jan; 25(1):29-40. PubMed ID: 27282644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A key role by polymers in microneedle technology: a new era.
    Rajput A; Kulkarni M; Deshmukh P; Pingale P; Garkal A; Gandhi S; Butani S
    Drug Dev Ind Pharm; 2021 Nov; 47(11):1713-1732. PubMed ID: 35332822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microneedles and transdermal applications.
    Sivamani RK; Liepmann D; Maibach HI
    Expert Opin Drug Deliv; 2007 Jan; 4(1):19-25. PubMed ID: 17184159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays.
    van der Maaden K; Luttge R; Vos PJ; Bouwstra J; Kersten G; Ploemen I
    Drug Deliv Transl Res; 2015 Aug; 5(4):397-406. PubMed ID: 26044672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays.
    Allen LV
    Int J Pharm Compd; 2023; 27(1):30-37. PubMed ID: 36720061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.